The side effect profile of buspirone in comparison to active controls and placebo.
Animal studies and the original study comparing buspirone with diazepam and placebo indicated that sedative-hypnotic side effects and impairment in psychomotor function would be less with buspirone than with diazepam. This was borne out by the present double-blind study in which almost 700 patients received buspirone. Mean daily doses were buspirone, 20 mg; diazepam, 20 mg; and clorazepate, 24 mg. Sedation, lethargy, and depression were significantly less with buspirone than with diazepam or clorazepate and were comparable to placebo. There was no indication that other types of side effects would differ significantly from those seen with the benzodiazepines. Nervousness, headache, and dizziness were experienced more frequently with buspirone than with placebo.
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced; D003975:Diazepam / Q000009:adverse effects; D004311:Double-Blind Method; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011743:Pyrimidines / Q000009:adverse effects*; D012894:Sleep Stages
D014151:Anti-Anxiety Agents; D010919:Placebos; D011743:Pyrimidines; D003009:Clorazepate Dipotassium; D003975:Diazepam; D002065:Buspirone